We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SSNI
176
DELISTED
Silver Spring Networks, Inc.
SSNI
| $1.3M | 0.19% |
88,421
+52,649
| +147% | +$657K |
|
177
Enova International
ENVA
$5.91B
| $1.3M | 0.19% |
206,558
+13,492
| +7% | +$80.6K |
|
|
DCH
178
Dauch Corp
DCH
$1.3B
| $1.3M | 0.19% |
+84,599
| New | +$1.22M |
|
179
Boise Cascade
BCC
$2.74B
| $1.3M | 0.19% |
62,832
-13,588
| -18% | -$256K |
|
|
MCF
180
DELISTED
Contango Oil & Gas Co.
MCF
| $1.3M | 0.19% |
110,362
+73,857
| +202% | +$512K |
|
181
Selective Insurance
SIGI
$5.74B
| $1.29M | 0.19% |
+35,386
| New | +$1.17M |
|
|
DCOM
182
DELISTED
Dime Community Bancshares
DCOM
| $1.29M | 0.19% |
73,398
-260,516
| -78% | -$4.41M |
|
183
Tredegar Corp
TG
$268M
| $1.29M | 0.19% |
+82,191
| New | +$1.12M |
|
184
Lumentum
LITE
$59.4B
| $1.29M | 0.19% |
+47,730
| New | +$1.1M |
|
|
AMED
185
DELISTED
Amedisys
AMED
| $1.27M | 0.18% |
+26,364
| New | +$1.02M |
|
186
Lexicon Pharmaceuticals
LXRX
$1.02B
| $1.27M | 0.18% |
+106,319
| New | +$1.11M |
|
|
TEN
187
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $1.27M | 0.18% |
+24,607
| New | +$1.08M |
|
|
NXTM
188
DELISTED
NxStage Medical Inc.
NXTM
| $1.26M | 0.18% |
84,383
+15,673
| +23% | +$263K |
|
|
TLRD
189
DELISTED
Tailored Brands, Inc.
TLRD
| $1.26M | 0.18% |
+70,531
| New | +$1.09M |
|
190
ANI Pharmaceuticals
ANIP
$1.77B
| $1.26M | 0.18% |
37,354
+25,052
| +204% | +$850K |
|
|
ALJ
191
DELISTED
Alon USA Energy Inc
ALJ
| $1.26M | 0.18% |
121,694
+95,239
| +360% | +$1.08M |
|
|
FUEL
192
DELISTED
Rocket Fuel Inc.
FUEL
| $1.25M | 0.18% |
396,678
-184,399
| -32% | -$597K |
|
|
FFWM
193
DELISTED
First Foundation Inc
FFWM
| $1.23M | 0.18% |
109,924
+9,904
| +10% | +$109K |
|
194
Kforce
KFRC
$983M
| $1.23M | 0.18% |
62,752
-27,099
| -30% | -$522K |
|
195
DHI Group
DHX
$166M
| $1.22M | 0.18% |
151,526
+17,111
| +13% | +$141K |
|
|
AAMI
196
Acadian Asset Management
AAMI
$2.88B
| $1.22M | 0.18% |
91,483
-16,263
| -15% | -$194K |
|
197
Extreme Networks
EXTR
$3.86B
| $1.22M | 0.18% |
392,186
+329,902
| +530% | +$1.01M |
|
|
RRTS
198
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $1.21M | 0.17% |
3,892
-508
| -12% | -$133K |
|
|
LHCG
199
DELISTED
LHC Group LLC
LHCG
| $1.21M | 0.17% |
+33,995
| New | +$1.25M |
|
200
Unisys
UIS
$227M
| $1.21M | 0.17% |
156,656
+136,015
| +659% | +$1.29M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.